Araceli Biosciences

About

Araceli Biosciences is a biotechnology company based in Portland, founded in 2020. The company focuses on accelerating drug discovery and therapeutic development through advanced imaging systems and AI-driven analysis. Araceli aims to empower researchers with tools that reduce drug discovery timelines and enhance therapeutic success rates. Their flagship product, the Endeavor High Content Imaging System, offers ultra-high-throughput imaging, capturing cellular response data significantly faster than traditional systems. This system is complemented by Clairvoyance, an AI analysis software that processes imaging data in real time, providing immediate insights into cellular assays. Araceli's solutions are designed to improve efficiency in compound screening, biomarker discovery, and therapeutic validation, ultimately aiming to shorten the lengthy drug development cycle. Araceli has secured $11.2 million in seed funding to expand its operations and enhance its analysis capabilities. The company serves pharmaceutical firms, biotech researchers, and academic labs, focusing on optimizing high-content screening workflows and enabling faster decision-making in drug development.